What is KidneyX?
The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the U.S. Department of Health and Human Services and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.
KidneyX seeks to improve the lives of the 850 million people currently affected worldwide by accelerating the development of drugs, devices, biologics and other therapies across the spectrum of kidney care including: Prevention, Diagnostics and Treatment.
“We admit readily that we do not have the answers for this. We are reaching out. This accelerator program on innovation should be seen as the beginning of a partnership with this community and others. We need everyone’s help to go forward and make a difference.” – Bruce D. Greenstein, Chief Technology Officer, U.S. Department of Health and Human Services.
How will KidneyX Succeed?
Building off the success of similar public-private accelerators, KidneyX will engage a community of researchers, innovators, and investors to bring breakthrough therapies to patients by:
Driving patient access to disruptive technologies via competitive, merit-based prize funding to innovators.
Providing a clearer and less expensive path to bringing products to patients and their families.
Creating a sense of urgency by spotlighting the immediate needs of patients and their families.
KidneyX’s first round of prize funding will focus on accelerating the commercialization of
next-generation dialysis products. The first opportunity to apply to participate will be in 2018.